Rxivist logo

For yet unknown reasons, severely ill COVID-19 patients often become critically ill around the time of activation of adaptive immunity. Here, we show that anti-Spike IgG from serum of severely ill COVID-19 patients induces a hyper-inflammatory response by human macrophages, which subsequently breaks pulmonary endothelial barrier integrity and induces microvascular thrombosis. The excessive inflammatory capacity of this anti-Spike IgG is related to glycosylation changes in the IgG Fc tail. Moreover, the hyper-inflammatory response induced by anti-Spike IgG can be specifically counteracted in vitro by use of the active component of fostamatinib, an FDA- and EMA-approved therapeutic small molecule inhibitor of Syk. ### Competing Interest Statement The authors have declared no competing interest.

Download data

  • Downloaded 5,848 times
  • Download rankings, all-time:
    • Site-wide: 612 out of 94,912
    • In immunology: 18 out of 2,857
  • Year to date:
    • Site-wide: 187 out of 94,912
  • Since beginning of last month:
    • Site-wide: 14 out of 94,912

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)